Dup15q Alliance is proud to be a founding organization for the Commission on Novel Technology in Neurodevelopmental Copy Number Variants (CNVs)
Knowing there needs to be new technology to support genetic disorders with multiple copy numbers and large anomalies. Dup15q Alliance teamed up with Project 8P and Ring 14 (both rare disorders with large chromosome anomalies) to develop the Commission for Neurodevelopmental CNV’s The commission aims to investigate the challenges common to neurodevelopmental disorders involving copy number changes (duplications or deletions) involving multiple genes in order to accelerate therapeutic developments.
Mission:
To establish a Commission that is a patient-driven collaborative group of stakeholders to advance novel technologies to treat neurodevelopmental diseases with large chromosome anomalies.
With hope and perseverance, everything is possible
No one knows a disease better than those who live it every day. Patients’ active involvement is critical for accelerating the development of treatments .The Rare As One grant will support Project 8p’s collaboration with the Dup15q Alliance, another patient-led advocacy group, to develop the Commission on Novel Technologies for Neurodevelopmental Copy Number Variants (CNVs). The Commission, recently founded by the two organizations, aims to investigate the challenges common to neurodevelopmental CNVs in order to accelerate therapeutic developments.
“Patients’ active involvement is critical for accelerating the development of treatments.”
Founding Patient Organizations: Project 8p, Dup15Q Alliance, Ring14 USA